Medicine guide

GENVOYA

As listed in the register: GENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculé

150 mg + 200 mg + 11,2 mg + 150 mg · comprimé pelliculé

  • Prescription only
Made by
GILEAD SCIENCES IRELAND UC (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Details

Made byGILEAD SCIENCES IRELAND UC (IRLANDE)
Active substanceCobicistat + Emtricitabine + Fumarate De Ténofovir Alafénamide + Elvitégravir
Strength150 mg + 200 mg + 11,2 mg + 150 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)prescription initiale hospitalière annuelle · liste I · renouvellement non restreint
MarketedYes, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/15/1061
Name in the registerGENVOYA 150 mg/150 mg/200 mg/10 mg, comprimé pelliculé
Packs1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
CIS65453475
CIP133400930037737

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).